Home » Newsletters » BioWorld Science

BioWorld Science

March 6, 1998

View Archived Issues

PKC antisense oligonucleotide shows promise in cancer therapy

Pharmacia & Upjohn: Q4 1997 highlights

Promotion agreement established for wound-healing drugs

Xoma: Q4 and year-end 1997 highlights

AxyS Pharmaceuticals: Q4 and year-end 1997 highlights

FDA approves expanded indications for Dynabac

Intercardia to acquire Transcell

Matritech: Q4 and year-end 1997 highlights

Hexagen and Genzyme Molecular Oncology establish SAGE agreement

Atrix: Q4 and year-end 1997 highlights

Succinamide derivatives for inhibiting MMPs and/or TNF production

Antitumor agents isolated from fungal strains by Roche

HMR prepares new antibacterial agents for Gram-positive infections

Astra develops new gastric antisecretory agents

Pharmacia & Upjohn presents new tyrosine kinase inhibitors

Xanthene derivatives useful for neurodegenerative disorders

Arthritis Advisory Committee meets later this month

Second market introduction for lercanidipine

FDA will give priority review to nitazoxanide

Droxia approved by FDA for sickle cell anemia

Receptagen and Scitech Genetics terminate merger proceedings

Forbes Medi-Tech files patent application covering AD prevention

AnervaX peptide vaccine successfully completes phase IIa trial

New indication for Mobic cleared by U.K. authorities

Targeted apoptosis as a novel therapeutic strategy in vascular disease

Preliminary results reported from phase II trials of Vitrase

Yamanouchi engages in NK antagonist research

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...